omplications of inﬂuenza infection constitute a further under- most likely to spread during the upcoming season, for inclusio
ecognised disease burden4,5. Overall, such a high disease burden the vaccine. Identiﬁcation of the target inﬂuenza strains is b
arries substantial social and economic cost6,7. Prevention of on surveillance data collected by World Health Organiza
easonal inﬂuenza epidemics, as well as preparedness for future (WHO) collaborating centres at six locations in the UK,
andemics, is thus a global priority. (including the Centers for Disease Control and Prevention [C
Inﬂuenza A subtypes H1N1 and H3N2, and inﬂuenza B lineages Japan, China and Australia as part of the WHO Global Inﬂu
/Yamagata and B/Victoria circulate routinely in humans and are Surveillance and Response System (GISRS)15. The ﬁnal decisio
ncluded in seasonal inﬂuenza vaccines8. Inﬂuenza A subtypes can resulting vaccine targets is made by individual regulatory bo